FindTrial
Sign In

The effect of icodextrin and low calcium dialysate to prevent hypervolemia and CKD-MBD(chronic kidney disease-- mineral bone disorder)

The effect of icodextrin and low calcium dialysate to prevent hypernatremia and hypercalcemia on APD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004922
Enrollment
784
Registered
2020-04-16
Start date
2020-04-03
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yeongnam University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among 784 incident peritoneal dialysis patients since Jan 1, 2001, about 100 incident peritoneal dialysis patients who maintained APD more than 12 months and who followed fulfilled peritoneal dialysis protocol (PET, BIA and DEXA) were enrolled (more than 18 years old) in our Hospital.

Exclusion criteria

Exclusion criteria: APD patients who didn’t finish more than 1 year follow-up protocol including BIA, DEXA and PET data.

Design outcomes

Primary

MeasureTime frame
Edema index(extracellular water/total body water);Bone mineral density—

Secondary

MeasureTime frame
serum sodium concentration;serum intact parathyroid hormone level, calcium, phosphate concentration—

Countries

Korea, Republic of

Contacts

Public ContactJun Young Do

Yeongnam University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026